Differences in the Molecular Species of CA125 Across the Phases of the Menstrual Cycle

Monica R. McLemore, Christine Miaskowski, Kathryn Lee, Lee May Chen, Bradley E. Aouizerat

Research output: Contribution to journalArticle

Abstract

Background: CA125, a tumor-associated antigen, is primarily used to monitor epithelial ovarian cancer. There is evidence that different species of CA125 exist; however, it is not known if any of these species are present in healthy women during the menstrual cycle and if they are associated with serum concentrations of CA125. The purpose of this study was to determine if the molecular species of CA125 differ across the three phases of the menstrual cycle in healthy women. Methods: Healthy, Caucasian women between the ages of 18 and 39 were enrolled using strict criteria to exclude factors known to contribute to CA125 fluctuations. Menstrual cycle regularity was determined using calendars maintained by participants for 3 months. After cycle regularity was established, blood was drawn at three time points for Western blot analysis. Results: Western blot analysis yielded 17 distinct profiles (i.e., patterns of species) of CA125, with 80% of the sample exhibiting 5 common profiles. No differences in demographic characteristics and serum CA125 values were found among the various CA125 profiles. Conclusions: Different molecular species of CA125 exist in healthy women with regular menstrual cycles. These data provide evidence that CA125 is not a homogeneous molecular species. Future research should evaluate the molecular composition and the clinical importance of these species.

Original languageEnglish (US)
Pages (from-to)23-30
Number of pages8
JournalBiological Research for Nursing
Volume18
Issue number1
DOIs
StatePublished - Jan 1 2016

Fingerprint

Menstrual Cycle
Western Blotting
Neoplasm Antigens
Serum
Demography

Keywords

  • CA125
  • menstrual cycle
  • molecular speciation

ASJC Scopus subject areas

  • Research and Theory

Cite this

Differences in the Molecular Species of CA125 Across the Phases of the Menstrual Cycle. / McLemore, Monica R.; Miaskowski, Christine; Lee, Kathryn; Chen, Lee May; Aouizerat, Bradley E.

In: Biological Research for Nursing, Vol. 18, No. 1, 01.01.2016, p. 23-30.

Research output: Contribution to journalArticle

McLemore, Monica R. ; Miaskowski, Christine ; Lee, Kathryn ; Chen, Lee May ; Aouizerat, Bradley E. / Differences in the Molecular Species of CA125 Across the Phases of the Menstrual Cycle. In: Biological Research for Nursing. 2016 ; Vol. 18, No. 1. pp. 23-30.
@article{794ff47a1ff8445fa017954e5fb6abd8,
title = "Differences in the Molecular Species of CA125 Across the Phases of the Menstrual Cycle",
abstract = "Background: CA125, a tumor-associated antigen, is primarily used to monitor epithelial ovarian cancer. There is evidence that different species of CA125 exist; however, it is not known if any of these species are present in healthy women during the menstrual cycle and if they are associated with serum concentrations of CA125. The purpose of this study was to determine if the molecular species of CA125 differ across the three phases of the menstrual cycle in healthy women. Methods: Healthy, Caucasian women between the ages of 18 and 39 were enrolled using strict criteria to exclude factors known to contribute to CA125 fluctuations. Menstrual cycle regularity was determined using calendars maintained by participants for 3 months. After cycle regularity was established, blood was drawn at three time points for Western blot analysis. Results: Western blot analysis yielded 17 distinct profiles (i.e., patterns of species) of CA125, with 80{\%} of the sample exhibiting 5 common profiles. No differences in demographic characteristics and serum CA125 values were found among the various CA125 profiles. Conclusions: Different molecular species of CA125 exist in healthy women with regular menstrual cycles. These data provide evidence that CA125 is not a homogeneous molecular species. Future research should evaluate the molecular composition and the clinical importance of these species.",
keywords = "CA125, menstrual cycle, molecular speciation",
author = "McLemore, {Monica R.} and Christine Miaskowski and Kathryn Lee and Chen, {Lee May} and Aouizerat, {Bradley E.}",
year = "2016",
month = "1",
day = "1",
doi = "10.1177/1099800414565879",
language = "English (US)",
volume = "18",
pages = "23--30",
journal = "Biological Research for Nursing",
issn = "1099-8004",
publisher = "SAGE Publications Inc.",
number = "1",

}

TY - JOUR

T1 - Differences in the Molecular Species of CA125 Across the Phases of the Menstrual Cycle

AU - McLemore, Monica R.

AU - Miaskowski, Christine

AU - Lee, Kathryn

AU - Chen, Lee May

AU - Aouizerat, Bradley E.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Background: CA125, a tumor-associated antigen, is primarily used to monitor epithelial ovarian cancer. There is evidence that different species of CA125 exist; however, it is not known if any of these species are present in healthy women during the menstrual cycle and if they are associated with serum concentrations of CA125. The purpose of this study was to determine if the molecular species of CA125 differ across the three phases of the menstrual cycle in healthy women. Methods: Healthy, Caucasian women between the ages of 18 and 39 were enrolled using strict criteria to exclude factors known to contribute to CA125 fluctuations. Menstrual cycle regularity was determined using calendars maintained by participants for 3 months. After cycle regularity was established, blood was drawn at three time points for Western blot analysis. Results: Western blot analysis yielded 17 distinct profiles (i.e., patterns of species) of CA125, with 80% of the sample exhibiting 5 common profiles. No differences in demographic characteristics and serum CA125 values were found among the various CA125 profiles. Conclusions: Different molecular species of CA125 exist in healthy women with regular menstrual cycles. These data provide evidence that CA125 is not a homogeneous molecular species. Future research should evaluate the molecular composition and the clinical importance of these species.

AB - Background: CA125, a tumor-associated antigen, is primarily used to monitor epithelial ovarian cancer. There is evidence that different species of CA125 exist; however, it is not known if any of these species are present in healthy women during the menstrual cycle and if they are associated with serum concentrations of CA125. The purpose of this study was to determine if the molecular species of CA125 differ across the three phases of the menstrual cycle in healthy women. Methods: Healthy, Caucasian women between the ages of 18 and 39 were enrolled using strict criteria to exclude factors known to contribute to CA125 fluctuations. Menstrual cycle regularity was determined using calendars maintained by participants for 3 months. After cycle regularity was established, blood was drawn at three time points for Western blot analysis. Results: Western blot analysis yielded 17 distinct profiles (i.e., patterns of species) of CA125, with 80% of the sample exhibiting 5 common profiles. No differences in demographic characteristics and serum CA125 values were found among the various CA125 profiles. Conclusions: Different molecular species of CA125 exist in healthy women with regular menstrual cycles. These data provide evidence that CA125 is not a homogeneous molecular species. Future research should evaluate the molecular composition and the clinical importance of these species.

KW - CA125

KW - menstrual cycle

KW - molecular speciation

UR - http://www.scopus.com/inward/record.url?scp=84950341782&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84950341782&partnerID=8YFLogxK

U2 - 10.1177/1099800414565879

DO - 10.1177/1099800414565879

M3 - Article

VL - 18

SP - 23

EP - 30

JO - Biological Research for Nursing

JF - Biological Research for Nursing

SN - 1099-8004

IS - 1

ER -